课题基金 / 基金详情

EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS

EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
囊性纤维化中的细胞外核苷酸信号转导
批准号:
6044885
负责人:
Erik Mills Schwiebert
金额:
$18.77万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-15 至 2004-11-30

项目摘要

项目成果

Erik Mills Schwiebert的其他基金

相似基金

相关文献

中文摘要
翻译
囊性纤维化(CF)是一种外分泌上皮疾病。 不仅是缺乏环AMP激活的氯离子(C1-)通道活性观察CF上皮细胞,但其他上皮C1-和Na+通道,上皮囊泡运输,上皮免疫功能失调也观察到CF。 PI最近显示,在基础或等渗和低渗条件下,CF上皮细胞的顶膜上ATP释放损失,并且CF中细胞外ATP信号传导可能丢失。 在CF上皮细胞中没有基础或刺激的ATP释放的情况下,我们假设CF上皮功能障碍的发病机制可能在于CF上皮细胞的ATP信号传导缺陷和细胞体积调节缺陷。 已经观察到气道表面液体中的离子不平衡;我们假设这反映了由于上皮细胞体积调节的自分泌ATP控制的固有缺陷而导致的渗透压不平衡。 因此,这个完全重建的建议集中在一个简洁的中心假设:ATP释放和信号传导对于细胞体积调节的自分泌控制至关重要。 这一假设有两个目的:(1)检验RVD需要ATP释放、ATP受体和质膜中CFTR表达的假设;(2)检验ATP释放通过转运和胞外分泌驱动机制发生的假设。 为了实现这些目的,将亲本CF上皮细胞与用野生型CFTR瞬时或稳定补充的CF细胞进行比较。 将使用细胞体积调节试验、细胞释放ATP的生物发光检测试验、ATP全细胞电流和膜电容的膜片钳电生理学试验以及胞吐试验的协同组合来解决每个目标。 这些试验将确定ATP释放机制,这些机制对CFTR表达的依赖性,以及参与细胞体积调节的自分泌ATP控制的嘌呤能受体。 我们相信,新的结果将被发现有关的细胞和分子机制的自分泌ATP的释放,信号,和调节细胞体积。
英文摘要
Cystic fibrosis (CF) is a disease of exocrine epithelia. Not only is a lack of cyclic AMP-activated chloride (C1-) channel activity observed in CF epithelial cells, but dysregulation of other epithelial C1- and Na+ channels, epithelial vesicle trafficking, and epithelial immune function are also observed in CF. The PI has shown recently that there is a loss of ATP release across the apical membrane of CF epithelia under basal or isotonic and hypotonic conditions and that extracellular ATP signaling may be lost in CF. Without basal or stimulated ATP release in CF epithelia, we hypothesize that the pathogenesis of CF epithelial dysfunction may lie in defective ATP signaling and defective cell volume regulation by the CF epithelia. An ionic imbalance in the airway surface liquid has been observed; we hypothesize that this reflects an osmotic imbalance due to an inherent defect in autocrine ATP control of epithelial cell volume regulation. As such, this completely re-constructed proposal focuses on one concise, central hypothesis: ATP release and signaling is essential for autocrine control of cell volume regulation. Two aims derive from this hypothesis: (1) Test the hypothesis that RVD requires ATP release, ATP receptors, and CFTR expression in the plasma membrane, and (2) Test the hypothesis that ATP release occurs via transport- and exocytotic-driven mechanisms. To fulfill these Aims, parental CF epithelial cells will be compared to CF cells complemented transiently or stably with wild-type CFTR. A synergistic combination of cell volume regulation assays, bioluminescence detection assays of ATP released from cells, patch-clamp electrophysiological assays of ATP whole cell current and membrane capacitance, and exocytosis assays will be used to address each Aim. These assays will identify the ATP release mechanisms, the dependence of these mechanisms upon CFTR expression, and the purinergic receptors involved in autocrine ATP control of cell volume regulation. We are confident that novel results will be found concerning the cellular and molecular mechanisms of autocrine ATP release, signaling, and regulation of cell volume.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
  • 批准号:
    9139596
  • 项目类别:
  • 资助金额:
    $36.62万
  • 财政年份:
    2016
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
  • 批准号:
    8454042
  • 项目类别:
  • 资助金额:
    $43.66万
  • 财政年份:
    2013
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
  • 批准号:
    8803107
  • 项目类别:
  • 资助金额:
    $50.34万
  • 财政年份:
    2013
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
  • 批准号:
    8892174
  • 项目类别:
  • 资助金额:
    $63.17万
  • 财政年份:
    2013
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
海外基金